A carregar...
Nanocarrier-based drug combination therapy for glioblastoma
The current achievements in treating glioblastoma (GBM) patients are not sufficient because many challenges exist, such as tumor heterogeneity, the blood brain barrier, glioma stem cells, drug efflux pumps and DNA damage repair mechanisms. Drug combination therapies have shown increasing benefits ag...
Na minha lista:
| Publicado no: | Theranostics |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ivyspring International Publisher
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6956816/ https://ncbi.nlm.nih.gov/pubmed/31938069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.38147 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|